Dynex Capital Increases Share Availability Amid Market Weakness
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Jan 27 2026
0mins
Should l Buy DX?
Source: seekingalpha
Dynex Capital's stock fell by 5.01% as it crossed below the 5-day SMA, reflecting broader market weakness with the Nasdaq-100 down 1.46% and S&P 500 down 0.64%.
The company announced an amendment to its distribution agreement, increasing the number of shares available for sale by 60 million to a total of 221.29 million shares. This move is aimed at enhancing market liquidity and providing more options for future financing. Despite a decline in Q4 earnings due to rising expenses, Dynex reported increases in book value and net interest income, indicating a degree of financial health amidst challenges.
This increase in share availability may help Dynex navigate its funding needs more effectively, but the current market conditions could pose challenges for its stock performance in the near term.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy DX?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on DX
Wall Street analysts forecast DX stock price to rise
2 Analyst Rating
2 Buy
0 Hold
0 Sell
Moderate Buy
Current: 13.870
Low
14.50
Averages
15.25
High
16.00
Current: 13.870
Low
14.50
Averages
15.25
High
16.00
About DX
Dynex Capital, Inc. is a financial services company. The Company is an internally managed mortgage real estate investment trust (REIT), which invests in mortgage-backed securities (MBS). It finances its investments principally with repurchase agreements. Its objective is to provide attractive risk-adjusted returns to its shareholders over the long term that are reflective of a leveraged, high-quality fixed income portfolio with a focus on capital preservation. It seeks to provide returns to its shareholders primarily through the payment of regular dividends and through capital appreciation of its investments. It primarily invests in Agency MBS, of which over 97% are residential MBS (Agency RMBS), including to-be-announced (TBA) securities. The remainder of its investment portfolio consists of Agency commercial MBS (Agency CMBS) and Agency and non-Agency CMBS interest-only (CMBS IO) securities.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Analysis of Insider Buying in Kingsbarn ETF
- Insider Buying Ratio: The Kingsbarn Dividend Opportunity ETF (DVDN) shows that 18.0% of its weighted holdings have experienced insider buying in the past six months, indicating management's confidence in future growth, which may attract more investor interest in the ETF.
- Arbor Realty Trust Activity: Arbor Realty Trust Inc (ABR), making up 7.24% of DVDN, has seen 4 directors and officers purchase shares in the past six months, reflecting optimism among insiders about the company's future performance, potentially boosting market confidence in the stock.
- Dynex Capital Purchases: Dynex Capital Inc (DX), the fifth largest holding in DVDN, has $185,144 worth of shares held in the ETF, representing approximately 6.05% of total assets, with 2 directors and officers recently filing Form 4s, indicating insider optimism that could influence the stock's price trajectory.
- ETF Investment Strategy: The increase in insider buying activity within the Kingsbarn Dividend Opportunity ETF's portfolio may enhance its overall investment appeal, especially in the current market environment where investors are likely to favor stocks that insiders are optimistic about.
See More
Dynex Capital Appoints New CFO Michael Sartori
- Executive Change: Dynex Capital has appointed Michael Sartori as Chief Financial Officer, effective immediately, indicating a strategic shift in the company's approach to capital markets and financial planning aimed at enhancing financial management efficiency.
- Transition Support: Former CFO Robert Colligan will remain in an advisory role until May 1, 2026, facilitating a smooth transition for the management team, which is crucial for maintaining investor confidence and operational stability.
- Market Concerns: Despite Dynex Capital's earnings performance attracting attention, market analysts express skepticism regarding the sustainability of its high yield, which could impact investor perceptions of the company's future financial health.
- Capital Raising: Dynex Capital's recent $1.5 billion capital raise signals the company's intent to adopt a tighter spread management strategy in the current economic environment, aiming to enhance shareholder returns, which have reached 29.4%.
See More
Dynex Capital Increases Share Availability by 60M
- Increased Share Availability: Dynex Capital announced an amendment to its distribution agreement, increasing the number of shares available for sale by 60 million to a total of 221.29 million shares, enhancing market liquidity and providing more options for future financing.
- Remaining Issuable Shares: The company has 67.35 million shares still available for issuance, which supports its flexible operations in the capital markets and helps address future funding needs.
- Enhanced Shareholder Returns: While raising $1.5 billion in capital, Dynex signals a shift to a tighter spread regime, expected to yield a 29.4% return for shareholders, thereby boosting investor confidence.
- Financial Performance Fluctuations: Despite a decline in Q4 earnings due to rising expenses, the company reported increases in book value and net interest income, indicating a degree of financial health amidst challenges.
See More
Wall Street Analysts Adjust Ratings
- Acumen Price Target Raised: BTIG raised Acumen Pharmaceuticals' price target from $4 to $7, with analyst Thomas Shrader maintaining a Buy rating, indicating confidence in the company's growth potential despite a closing price of $2.08 on Monday.
- Exelixis Target Price Increase: HC Wainwright & Co. raised the price target for Exelixis from $49 to $52, with analyst Robert Burns maintaining a Buy rating, reflecting optimism about its market performance, closing at $43.61 on Monday.
- Baker Hughes Price Target Upgraded: BMO Capital increased Baker Hughes' price target from $55 to $65, with analyst Phillip Jungwirth maintaining an Outperform rating, suggesting a positive outlook on its future performance, closing at $56.29 on Monday.
- Brown & Brown Price Target Cut: B of A Securities lowered the price target for Brown & Brown from $94 to $90, with analyst Joshua Shanker maintaining a Neutral rating, indicating a cautious stance on the company's short-term performance, closing at $79.62 on Monday.
See More
Dynex Capital Achieves 29.4% Total Shareholder Return in 2025
- Significant Shareholder Return: Dynex Capital achieved a total shareholder return of 29.4% in 2025, driven by both dividend income and substantial share price performance, which bolstered investor confidence and enhanced market positioning.
- Asset Scale Expansion: The company's total equity market capitalization nearly tripled to $3 billion, enhancing financial resilience and strategic flexibility, thereby providing stronger support for future investments.
- Strong Liquidity Position: As of Q4 2025, Dynex Capital held $1.4 billion in cash and unencumbered securities, representing over 55% of total equity, ensuring stability in uncertain market conditions.
- Record Economic Return: The company's total economic return reached 21.7% in 2025, marking the highest level in a decade, reflecting effective capital deployment strategies and market adaptability.
See More
Dynex Capital Reports 29.4% Shareholder Return and Triples Market Cap in 2025
- Significant Shareholder Returns: Dynex Capital achieved a 29.4% total shareholder return in 2025, alongside notable share price performance and dividend income, demonstrating the company's successful capital management strategy.
- Market Capitalization Growth: The company's total equity market capitalization nearly tripled to $3 billion within 13 months, reflecting effective execution in capital raising and investment, thereby enhancing market confidence.
- Management Changes: Dynex appointed Meakin Bennett as Chief Operating Officer and expanded its legal and investment teams, aiming to improve operational efficiency and strategic focus to support future growth.
- Strong Financial Performance: The total economic return for Q4 was 10.2%, with comprehensive income reaching $190 million, showcasing the company's adaptability and profitability amid changing market conditions.
See More
Analysis of Insider Buying in Kingsbarn ETF
- Insider Buying Ratio: The Kingsbarn Dividend Opportunity ETF (DVDN) shows that 18.0% of its weighted holdings have experienced insider buying in the past six months, indicating management's confidence in future growth, which may attract more investor interest in the ETF.
- Arbor Realty Trust Activity: Arbor Realty Trust Inc (ABR), making up 7.24% of DVDN, has seen 4 directors and officers purchase shares in the past six months, reflecting optimism among insiders about the company's future performance, potentially boosting market confidence in the stock.
- Dynex Capital Purchases: Dynex Capital Inc (DX), the fifth largest holding in DVDN, has $185,144 worth of shares held in the ETF, representing approximately 6.05% of total assets, with 2 directors and officers recently filing Form 4s, indicating insider optimism that could influence the stock's price trajectory.
- ETF Investment Strategy: The increase in insider buying activity within the Kingsbarn Dividend Opportunity ETF's portfolio may enhance its overall investment appeal, especially in the current market environment where investors are likely to favor stocks that insiders are optimistic about.
See More
Dynex Capital Appoints New CFO Michael Sartori
- Executive Change: Dynex Capital has appointed Michael Sartori as Chief Financial Officer, effective immediately, indicating a strategic shift in the company's approach to capital markets and financial planning aimed at enhancing financial management efficiency.
- Transition Support: Former CFO Robert Colligan will remain in an advisory role until May 1, 2026, facilitating a smooth transition for the management team, which is crucial for maintaining investor confidence and operational stability.
- Market Concerns: Despite Dynex Capital's earnings performance attracting attention, market analysts express skepticism regarding the sustainability of its high yield, which could impact investor perceptions of the company's future financial health.
- Capital Raising: Dynex Capital's recent $1.5 billion capital raise signals the company's intent to adopt a tighter spread management strategy in the current economic environment, aiming to enhance shareholder returns, which have reached 29.4%.
See More
Dynex Capital Increases Share Availability by 60M
- Increased Share Availability: Dynex Capital announced an amendment to its distribution agreement, increasing the number of shares available for sale by 60 million to a total of 221.29 million shares, enhancing market liquidity and providing more options for future financing.
- Remaining Issuable Shares: The company has 67.35 million shares still available for issuance, which supports its flexible operations in the capital markets and helps address future funding needs.
- Enhanced Shareholder Returns: While raising $1.5 billion in capital, Dynex signals a shift to a tighter spread regime, expected to yield a 29.4% return for shareholders, thereby boosting investor confidence.
- Financial Performance Fluctuations: Despite a decline in Q4 earnings due to rising expenses, the company reported increases in book value and net interest income, indicating a degree of financial health amidst challenges.
See More
Wall Street Analysts Adjust Ratings
- Acumen Price Target Raised: BTIG raised Acumen Pharmaceuticals' price target from $4 to $7, with analyst Thomas Shrader maintaining a Buy rating, indicating confidence in the company's growth potential despite a closing price of $2.08 on Monday.
- Exelixis Target Price Increase: HC Wainwright & Co. raised the price target for Exelixis from $49 to $52, with analyst Robert Burns maintaining a Buy rating, reflecting optimism about its market performance, closing at $43.61 on Monday.
- Baker Hughes Price Target Upgraded: BMO Capital increased Baker Hughes' price target from $55 to $65, with analyst Phillip Jungwirth maintaining an Outperform rating, suggesting a positive outlook on its future performance, closing at $56.29 on Monday.
- Brown & Brown Price Target Cut: B of A Securities lowered the price target for Brown & Brown from $94 to $90, with analyst Joshua Shanker maintaining a Neutral rating, indicating a cautious stance on the company's short-term performance, closing at $79.62 on Monday.
See More
Dynex Capital Achieves 29.4% Total Shareholder Return in 2025
- Significant Shareholder Return: Dynex Capital achieved a total shareholder return of 29.4% in 2025, driven by both dividend income and substantial share price performance, which bolstered investor confidence and enhanced market positioning.
- Asset Scale Expansion: The company's total equity market capitalization nearly tripled to $3 billion, enhancing financial resilience and strategic flexibility, thereby providing stronger support for future investments.
- Strong Liquidity Position: As of Q4 2025, Dynex Capital held $1.4 billion in cash and unencumbered securities, representing over 55% of total equity, ensuring stability in uncertain market conditions.
- Record Economic Return: The company's total economic return reached 21.7% in 2025, marking the highest level in a decade, reflecting effective capital deployment strategies and market adaptability.
See More
Dynex Capital Reports 29.4% Shareholder Return and Triples Market Cap in 2025
- Significant Shareholder Returns: Dynex Capital achieved a 29.4% total shareholder return in 2025, alongside notable share price performance and dividend income, demonstrating the company's successful capital management strategy.
- Market Capitalization Growth: The company's total equity market capitalization nearly tripled to $3 billion within 13 months, reflecting effective execution in capital raising and investment, thereby enhancing market confidence.
- Management Changes: Dynex appointed Meakin Bennett as Chief Operating Officer and expanded its legal and investment teams, aiming to improve operational efficiency and strategic focus to support future growth.
- Strong Financial Performance: The total economic return for Q4 was 10.2%, with comprehensive income reaching $190 million, showcasing the company's adaptability and profitability amid changing market conditions.
See More
